• AnteoTech’s AnteoBind Technology Supports COVID-19 Home Test americanpharmaceuticalreview
    February 23, 2021
    AnteoTech’s long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test.
  • AnteoTech develops high-sensitivity 15-min COVID-19 antigen test biospectrumasia
    August 22, 2020
    Brisbane based AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests utilize AnteoTech’s patented
PharmaSources Customer Service